Back to School: How biopharma can reboot drug development. Access exclusive analysis here

HK Pharma: This time, drugs

Hubert Koster has founded four biotech companies. The first three - Biosyntech GmbH, MilliGen/Biosearch and Sequenom Inc. - were focused developing new tools for biotech. This time around, Koster is going to try his hand at drug development. HK Pharmaceuticals Inc. has an approach to protein analysis that it believes will result in better characterized targets for drug development, with a particular focus on membrane-bound proteins.

"There are three components to our new philosophy of drug discovery and development," Koster said. "First,

Read the full 813 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers